Chris Evert Children's Hospital
Related Reading

Related Reading

Back to Document

Could Medication Be Causing Weight Gain?
Easy Ways to Remember to Take Your Medications
How to Get Medications for Less
Make Friends with Your Meds
Immunotherapy for Bladder Cancer
Targeted Therapies Take Aim at Cancer
What to Know About Immunotherapy for Kaposi Sarcoma
Cancer: If You Are Diagnosed With It
Cancer Survivor Tips
For Kids: When Someone You Love Has Cancer
For Teens: What to Expect If Your Loved One Has Cancer
Helpful Hints for Coping with the Holidays
Maintaining Quality of Life When You Have Cancer
Understanding the Provisions of Your Managed Care Plan
Cancer Overview
Enlist These Foods to Help Prevent Cancer
Appearance: Taking Control During Treatment
Appetite Stimulation
Cancer and Spirituality
Compassionate Drug Use
Constipation
Coping with Cancer Through Mind, Body, Spirit, and Emotions
Enteral Feeding
Fatigue: Definition
Hair Loss--One Woman's Story
Hypercalcemia (High Calcium Level in the Blood)
Hypersomnia
Insomnia
Inspirational Poems
Osteoporosis in Women with Cancer
Parental Cancer: Questions and Answers About Changes in Family Rhythms and Routines
Parenteral Feeding
Sexuality Issues for Women Being Treated for Cancer
Taste Changes
The 12 Most Common Approaches to Complementary Cancer Therapy
Understanding Cancer Statistics
Understanding Cancer Tests
Understanding Research Studies
First My Illness...Now Job Discrimination
Hormonal Therapy: Managing Side Effects in Women
Insurance Rights of Cancer Survivors
Now! Don't Wait!
Osteoporosis in Men with Cancer
Sample Appeal Letter for Services Denied as 'Not a Covered Benefit'
Struggling to Breathe: Tips for Managing Dyspnea
Your Employment Rights as a Cancer Survivor
Am I At Risk for nonMelanoma Skin Cancer?
Can I Get Checked for Nonmelanoma Skin Cancer?
Do What You Can to Ease Side Effects of Treatment for Nonmelanoma Skin Cancer
FDA-Approved Drugs
How Can I Prevent or Detect Skin Cancer?
I’ve Just Been Told I Have Nonmelanoma Skin Cancer
Tips for Feeling Your Best During and After Treatment for Nonmelanoma Skin Cancer
Understanding the Types of Skin Cancer
Understanding Your Stage of Nonmelanoma Skin Cancer
What Are the Symptoms of Nonmelanoma Skin Cancer?
What Is My Prognosis for Nonmelanoma Skin Cancer?
What to Know About Chemotherapy for Nonmelanoma Skin Cancer
What to Know About Radiation Therapy for Nonmelanoma Skin Cancer
What to Know About Surgery for Nonmelanoma Skin Cancer
Sunscreen and Skin Cancer
What To Do When You Find a Skin Abnormality
Medical Symptoms You Should Never Ignore
Coping with Dry Mouth During Cancer Therapy
Growing Up Short or Heavy Can Be Difficult
Help for Hair Loss
Helping Children Conquer Fear
Kids' Health Concerns Ease with Age
What Kids Drink Is Important, Too
Adrenal Cancer Chemotherapy
Chemotherapy for Acute Myeloid Leukemia (AML)
Chemotherapy for Esophageal Cancer
Chemotherapy: If You Are Considering It
Do What You Can to Ease Side Effects of Treatment for Carcinoma of Unknown Primary Origin
Goal of Chemotherapy for Breast Cancer
How Your Doctor Decides on Your Treatment Options for Acute Myeloid Leukemia (AML)
How Your Doctor Decides Your Treatment for Acute Lymphocytic Leukemia (ALL)
Making the Decision to Have a Stem Cell Transplant for Acute Lymphocytic Leukemia (ALL)
Making the Decision to Have Chemotherapy for Bladder Cancer
Take a ‘Vacation’ from Cancer
The 'Chemobrain' Phenomenon in Breast Cancer
Types of Treatment for Acute Lymphocytic Leukemia (ALL)
Types of Treatment for Acute Myeloid Leukemia (AML)
What Happens During Chemotherapy for Acute Lymphocytic Leukemia (ALL)
What Happens During Chemotherapy for Breast Cancer
What Happens During Chemotherapy for Cervical Cancer?
What Happens During Chemotherapy for CLL
What Happens With Systemic Chemotherapy for Bladder Cancer
What to Expect After Chemotherapy for Bladder Cancer
What to Expect After Chemotherapy for Breast Cancer
What to Expect After Chemotherapy for Kidney Cancer
What to Expect After Chemotherapy for Prostate Cancer
What to Expect After Taking Hormone Therapy Drugs for Breast Cancer
What to Know About Chemotherapy for Anal Cancer
What to Know About Chemotherapy for Bile Duct Cancer
What to Know About Chemotherapy for Bladder Cancer
What to Know About Chemotherapy for Brain Tumors
What to Know About Chemotherapy for Carcinoma of Unknown Primary Origin
What to Know About Chemotherapy for Ewing Sarcoma
What to Know About Chemotherapy for Gallbladder Cancer
What to Know About Chemotherapy for Kaposi Sarcoma
What to Know About Chemotherapy for Laryngeal Cancer
What to Know About Chemotherapy for Malignant Mesothelioma
What to Know About Chemotherapy for Primary Bone Cancer
Making the Decision to Have Radiation Therapy for Acute Lymphocytic Leukemia (ALL)
What Happens During a Stem Cell Transplant for Acute Lymphocytic Leukemia (ALL)
What Happens During a Stem Cell Transplant for Acute Myeloid Leukemia (AML)
What to Expect After a Stem Cell Transplant for Acute Lymphocytic Leukemia (ALL)
What to Expect After a Stem Cell Transplant for Acute Myeloid Leukemia (AML)
What to Know About Stem Cell Transplant for Hodgkin Disease
Am I At Risk for a Brain Tumor?
Coping with the Cognitive Effects of Brain Tumors
Do What You Can to Ease Side Effects of Treatment for a Brain Tumor
I've Just Been Told I Have a Brain Tumor
Rehabilitation for Children with Brain Tumors
Statistics About Brain Tumors
Support for a Loved One with a Brain Tumor
Targeted Therapy for Brain Tumors
Tell Your Health Care Team How You Feel During Treatment for a Brain Tumor
Tests that Help Evaluate a Brain Tumor
Tips for People With Brain Tumors
Types of Brain Tumors
Types of Treatment for Brain Tumors
Understanding Your Grade of Brain Tumor
What Are the Survival Rates for People With Brain Tumors?
What Are the Symptoms of a Brain Tumor?
What to Know About Radiation Therapy for Brain Tumors
What to Know About Surgery for Brain Tumors
Am I At Risk For Primary Bone Cancer?
How Does My Doctor Know I Have Primary Bone Cancer?
Statistics About Bone Cancer
Types and Goals of Treatment for Primary Bone Cancer
Types of Surgery for Primary Bone Cancer
Understanding Your Grade and Stage of Primary Bone Cancer
What Is Primary Bone Cancer?
Making the Decision to Have Radiation Therapy for Primary Bone Cancer
When Breast Cancer Spreads to the Bones

Chris Evert Children's Hospital Clinical Trials Program focuses on having available clinical trials to improve cancer care by finding better ways to treat cancer and help pediatric cancer patients.

The decision to enroll in a clinical trial is voluntary and one that should be made with the close consultation of a physician.

Research Physicians

Dr. Rodriguez-Cortes

Hector Rodriguez-Cortes, MD
Principal Investigator

Dr. Roskos

Rudolph Roskos, MD
Investigator

Dr. Cambara

Alejandro Cambara, MD
Investigator

Research Office Staff

Claudia Diaz Pow Sang, BSN, RN, CCRP, Clinical Research Coordinator
Arlene McMillan, BSN, RN, OCN, MS, Clinical Research Nurse/Regulatory

Contact Information

For further information, please contact the Pediatric Hematology/Oncology Research Department:

  • Principal Investigator 954-355-4527
  • Pediatric Hematology Oncology Research Office at 954-355-5488 or 954-712-6406
  • or visit: www.clinicaltrials.gov

Clinical Trials List

Updated: June 2014

Leukemia
AALL0232: High Risk B-precursor Acute Lymphoblastic Leukemia (ALL)
Status: Closed to enrollment / Open for transfer only
AALL0331: Standard Risk B-precursor Acute Lymphoblastic Leukemia
Status: Closed to enrollment / Open for transfer only
AALL03B1: Classification of Acute Lymphoblastic Leukemia
Status: Closed to enrollment / Open for transfer only
AALL0433: Intensive Treatment for Intermediate-Risk Relapse of Childhood B-Precursor Acute Lymphoblastic Leukemia (ALL): A Randomized Trial of Vincristine Strategies
Status: Closed to enrollment
AALL0434: Intensified Methotrexate, Nelarabine (Compound 506U78;IND #52611) and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-cell Acute Lymphoblastic Leukemia (ALL)
Status: Open to enrollment
AALL05B1: A Children's Oncology Group Protocol for Collecting and Banking Relapsed Acute Lymphoblastic Leukemia Research Specimens
Status: Open to enrollment
AALL07P1: A Phase II Pilot Trial of Bortezomib (PS-341, Velcade, IND# 58,443) in Combination with Intensive Re-Induction Therapy for Children with Relapsed Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LL)
Status: Open to enrollment
AALL08B1: The Classification of Acute Lymphoblastic Leukemia
Status: Open to enrollment
AALL0932: Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (ALL)
Status: Open to enrollment
AALL1131: A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum
Status: Open to enrollment
AAML0431: The Treatment of Down Syndrome Children with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Under the Age of 4 Years
Status: Closed to enrollment / Open for transfer only
AAML0531: A Phase III Randomized Trial of Gemtuzumab Ozogamicin (Mylotarg®) Combined with Conventional Chemotherapy for De Novo Acute Myeloid Leukemia (AML) in Children, Adolescents, and Young Adults
Status: Closed to enrollment / Open for transfer only
AAML1031: A Phase III Randomized Trial for Patients with de novo AML using Bortezomib (IND# 58443, NSC# 681239) and Sorafenib (BAY 43-9006, IND#69896, NSC# 724772) for Patients with High Allelic Ratio FLT3/ITD
Status: Open to enrollment
9904: ALinC 17 Treatment for Patients with Low Risk Acute Lymphoblastic Leukemia - A Phase III Study
Status: Closed to enrollment / Open for transfer only

Back to the Top

Brain & Spine
ACNS02B3: A Children's Oncology Group Protocol for Collecting and Banking Pediatric Brain Tumor Research Specimens
Status: Open to enrollment
ACNS0331: A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy 18.00 Gy and Chemotherapy In Children with Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Randomized Trial
Status: Open to enrollment
ACNS0334: A Phase III Randomized Trial for the Treatment of Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma in Children < 36 Months Old with Intensive Induction Chemotherapy with Methotrexate Followed by Consolidation with Stem Cell Rescue vs. the Same Therapy Without Methotrexate
Status: Open to enrollment
ACNS0831: Phase III Randomized Trial of Post-Radiation chemotherapy in Patients with NewlyDiagnosed Ependymoma Ages 1 to 21 Years
Status: Open to enrollment

Back to the Top

Ewing Sarcoma
AEWS07B1: A Children's Oncology Group Protocol for Collecting and Banking Ewing Sarcoma Specimens
Status: Open to enrollment
AEWS07P1: A Pilot Study of Chemotherapy Intensification by adding Vincristine, Topotecan and Cyclophosphamide to Standard Chemotherapy Agents with an Interval Compression Schedule in Newly Diagnosed Patients with Localized Ewing Sarcoma Family of Tumors
Status: Closed to enrollment / Open for transfer only
AEWS1031: A Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-metastatic Ewing Sarcoma
Status: Open to enrollment

Back to the Top

Germ Cell
AGCT0132: A Phase III Study of Reduced Therapy in the Treatment of Children with Low and Intermediate Risk Extracranial Germ Cell Tumors Closed to enrollment
Status: Open for transfer only

Back to the Top

Liver
AHEP0731: Treatment of Children with All Stages of Hepatoblastoma
Status: Open to enrollment

Back to the Top

Lymphoma
AHOD0031: A Phase III Study of Dose-Intensive, Response-Based Chemotherapy and Radiation Therapy for Children and Adolescents with Newly Diagnosed Intermediate Risk Hodgkin Disease
Status: Closed to enrollment / Open for transfer only
AHOD04B1: Hodgkin Disease Banking Study
Status: Open to enrollment

Back to the Top

Neuroblastoma
ANBL0032: Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue
Status: Open to enrollment
ANBL00B1: Neuroblastoma Biology Studies
Status: Open to enrollment
ANBL00P3: A Phase III randomized trial of Intravenous Gammaglobulin Therapy for Patients with Neuroblastoma Associated Opsoclonus-Myoclonus-Ataxia Syndrome Treated with Chemotherapy and Prednisone
Status: Closed to enrollment

Back to the Top

Osteosarcoma/Bone
AOST06B1: A Children's Oncology Group Protocol for Collecting and Banking Osteosarcoma Specimens
Status: Open to enrollment

Back to the Top

Renal/Kidney
AREN03B2: Renal Tumors Classification, Biology, and Banking Study
Status: Open to enrollment
AREN0532: Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Status: Closed to enrollment
AREN0534: Treatment for Patients with Bilateral, Multicentric, or Bilaterally-Predisposed Unilateral Wilms Tumor
Status: Open to enrollment

Back to the Top

Rhabdomyosarcoma (Soft Tissue Sarcoma)
ARST0331: Vincristine, Dactinomycin, and Lower Doses of Cyclophosphamide With or Without Radiation Therapy for Patients with Newly Diagnosed Low-Risk Embryonal/Botryoid/Spindle Cell Rhabdomyosarcoma
Status: Closed to enrollment / Open for transfer only
ARST0332: Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas in Patients Under 30 Years of Age
Status: Closed to enrollment / Open for transfer only
9902: A COG Soft Tissue Sarcoma Diagnosis, Biology and Banking Protocol
Status: Open to enrollment

Back to the Top

Other
ABTR01B1: A Children's Oncology Group Protocol for Collecting and Banking Pediatric Research Specimens Including Rare Pediatric Tumors
Status: Open to enrollment
ACCL0933: A Randomized Open-Label Trial of Caspofungin versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
Status: Open to enrollment
ACCRN07: Protocol for the Enrollment on the Official COG Registry, The Childhood Cancer Research Network (CCRN)
Status: Open to enrollment
ALTE05N1: Umbrella Long-term Follow-up Protocol
Status: Open to enrollment

Please call the Principal Investigator or Study coordinator with any questions or potential subjects.

Back to the Top